SEAN SAULS: Open Payments
NPI 1407963952 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,557 in 188 payments from 31 companies in 2025. Trend: 2023 $2,932 · 2024 $3,029 · 2025 $3,557
Food & beverage: $3,557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $584 |
| AstraZeneca Pharmaceuticals LP | 11 | $347 |
| PFIZER INC. | 18 | $304 |
| Sumitomo Pharma America, Inc. | 3 | $296 |
| Dexcom, Inc. | 12 | $216 |
| GlaxoSmithKline, LLC. | 14 | $195 |
| Lilly USA, LLC | 11 | $171 |
| Novo Nordisk Inc | 10 | $165 |
| SHIELD THERAPEUTICS INC | 13 | $157 |
| Amgen Inc. | 12 | $146 |
Products named: VRAYLAR, AIRSUPRA, GEMTESA, Dexcom G6 Transmitter, TRELEGY ELLIPTA, ACCRUFER, JARDIANCE, REXULTI.
Industry payments across GA — which companies pay providers there.
